Grants and Contributions:

Back to search

Title:

Research and development

Agreement Number:

971223

Agreement Value:

$48,333.00

Agreement Date:

May 1, 2021 - Feb 28, 2022

Description:

Endexo anti-thrombogenic additives, (not coatings) are low molecular weight fluoro-oligomers that impart a passive surface to the implantable medical device thereby reducing platelet adhesion and thrombus formation. Interface Biologics will perform research and development on the Endexo surface modifying technology in support of its partner(s). Feasibility and development of novel formulations to be tested and used in specific medical device applications will be conducted over the course of the project.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP’s Youth Employment Program is to assist in increasing the supply of highly qualified people, promoting the benefits of advanced studies, demonstrating federal leadership by investing in the skills required to meet the needs of the knowledge economy and facilitating the transition of highly skilled young people to a rapidly changing labour market.

Location:

Toronto, Ontario, CA M5G 1L7

Reference Number:

172-2021-2022-Q1-971223

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

871535910

Recipient Type:

For-profit organization

Recipient's Legal Name:

Interface Biologics Inc.

Federal Riding Name:

University--Rosedale

Federal Riding Number:

35110

Program:

Industrial Research Assistance Program – Youth Employment Program

Program Purpose:

Coverage:

IRAP Youth Employment Program projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

541710